期刊
STEM CELLS
卷 22, 期 7, 页码 1246-1255出版社
WILEY
DOI: 10.1634/stemcells.2004-0094
关键词
Parkinson's disease; cell therapy; human ES cells
Human embryonic stem cells (hESCs) may potentially serve as a renewable source of cells for transplantation. In Parkinson's disease, hESC-derived dopaminergic (DA) neurons may replace the degenerated neurons in the brain. Here, we generated highly enriched cultures of neural progenitors from hESCs and grafted the progenitors into the striatum of Parkinsonian rats. The grafts survived for at least 12 weeks, the transplanted cells stopped proliferating, and teratomas were not observed. The grafted cells differentiated in vivo into DA neurons, though at a low prevalence similar to that observed following spontaneous differentiation in vitro. Transplanted rats exhibited a significant partial correction of D-amphetamine and apomorphine-induced rotational behaviour, along with a significant improvement in stepping and placing nonpharmacological behavioural tests. While transplantation of uncommitted hESC-derived neural progenitors induced partial behavioural recovery, our data indicate that the host-lesioned striatum could not direct the transplanted neural progenitors to acquire a dopaminergic fate. Hence, induction of their differentiation toward a midbrain fate prior to transplantation is probably required for complete correction of behavioural deficit. Our observations encourage further developments for the potential use of hESCs in the treatment of Parkinson's disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据